Lakeland Industries, Inc. — FY2020 Form 10-K Summary
Reporting period: Fiscal year ended January 31, 2020, including Q4 FY2020. The request metadata identifies “2018 Q4,” but the supplied filing is the FY2020 Form 10-K, filed April 15, 2020.
Business context
Lakeland manufactures and sells industrial protective clothing and accessories, including disposable garments, chemical suits, firefighting and heat apparel, woven garments, high-visibility clothing, gloves and sleeves. Products are sold through approximately 1,600 distributors and other channels in more than 50 countries. The Company operates six manufacturing facilities in six countries and had 1,829 full-time employees at January 31, 2020.
Management’s strategy emphasizes higher-margin product lines, vertical-market sales teams, global manufacturing diversification, ERP-enabled planning, and expanded capacity in Vietnam and India.
Financial performance and key metrics
| Metric | FY2020 | FY2019 | Change |
|---|---|---|---|
| Net sales | $107.8 million | $99.0 million | +8.9% |
| Gross profit | $37.9 million | $33.9 million | +11.8% |
| Gross margin | 35.2% | 34.2% | +100 bps |
| Operating expenses | $32.0 million | $30.3 million | +5.5% |
| Operating profit | $5.9 million | $3.6 million | +64.9% |
| Operating margin | 5.5% | 3.6% | +190 bps |
| Net income | $3.3 million | $1.5 million | +125.0% |
| Diluted EPS | $0.41 | $0.18 | +0.23 |
| Cash flow from operations | $3.6 million | $1.8 million | +101.1% |
| Capital expenditures | $1.0 million | $3.1 million | Down $2.1 million |
Q4 FY2020 net sales were $28.2 million versus $25.0 million in Q4 FY2019. Q4 net income was $1.2 million versus a $1.9 million loss in the prior-year quarter. Q4 gross margin was 37.7%, compared with 27.7% in Q4 FY2019.
Product-line sales growth was led by chemical products, which increased to $23.0 million from $18.0 million, and fire products, which increased to approximately $8.6 million from $6.0 million. Disposable product sales were broadly stable at $53.4 million versus $53.2 million.
Liquidity, balance sheet and debt
- Cash and cash equivalents were $14.6 million at January 31, 2020, up from $12.8 million.
- Working capital was approximately $66.9 million, up $1.7 million year over year.
- Total assets were $99.4 million and stockholders’ equity was $85.1 million.
- Inventories increased to $44.2 million from $42.4 million, while accounts receivable increased to $17.7 million from $16.5 million.
- The Company had no revolver borrowings at year-end and approximately $1.2 million outstanding under its term loan. The term loan was prepaid on April 10, 2020.
- The $20 million secured revolving credit facility was scheduled to mature on May 10, 2020. Management was negotiating replacement financing. The facility was secured by substantially all U.S. assets and pledges of 65% of the equity of foreign subsidiaries.
- Operating lease liabilities totaled approximately $2.2 million at year-end following adoption of the lease standard.
- Cash flow benefited from higher net income and payables, but was partially offset by increases in receivables and inventory.
Material changes versus the prior comparable period
- Revenue growth was concentrated in the Americas, particularly the United States, Canada and Latin America. Europe and most other markets were essentially flat.
- Gross margins improved due to higher volumes, product mix, lower freight-in costs, direct-container shipments and improved manufacturing efficiency, particularly in Vietnam.
- Operating expenses grew more slowly than sales, reducing the expense ratio to 29.7% from 30.6%.
- FY2020 included an approximately $1.0 million non-cash GILTI tax expense, compared with $0.6 million in FY2019, contributing to a 43.0% effective tax rate.
- The Company recorded a $0.4 million additional expense related to Brazil labor claims and paid approximately $1.4 million in Brazilian professional fees and labor claims. The related accrual declined to $0.2 million from $1.2 million.
- A change in estimates for performance-based restricted stock awards reversed approximately $835,000 of previously recognized stock-based compensation expense.
- The Company repurchased 47,153 shares for approximately $506,000 during FY2020. No cash dividends have been paid since 2006, and dividends are restricted by the credit agreement.
- The ERP system rollout improved planning, lead times and manufacturing efficiency in U.S. operations, but inventory valuation controls remained a material weakness.
Guidance, outlook, commentary and risks
- Management anticipated strong sales in Q1 and Q2 FY2021 from COVID-19-related demand, followed by possible moderation as customers consume stockpiled inventory and economic conditions weaken.
- The Company planned to maximize disposable and chemical production, operating certain facilities 12 hours per day, seven days per week, while reducing SKUs to improve throughput and limit excess inventory risk.
- Management expected possible secondary government PPE stockpiling demand after the pandemic, but timing and volume were uncertain.
- FY2021 capital expenditures were expected to be approximately $2.0 million, primarily for global ERP deployment, strategic capacity expansion and equipment replacement.
- Research and development spending was expected to remain approximately $0.7 million according to MD&A, although the notes separately report FY2020 R&D expense of approximately $0.2 million; the filing text does not clearly reconcile these figures.
- Key risks include COVID-19 disruptions, export restrictions, supply-chain interruptions, foreign currency volatility, tariffs and trade disputes, Brexit-related uncertainty, competitive pricing pressure, seasonal demand, customer forecasting errors, product liability, environmental liabilities and cybersecurity incidents.
- Management identified a material weakness in inventory costing and valuation controls. The independent auditor issued an adverse opinion on internal control over financial reporting, although it issued an unqualified opinion on the consolidated financial statements.
- The Company’s disclosure controls were considered ineffective as of January 31, 2020 because of the material weakness. Remediation included standardizing inventory policies, improving bill-of-material controls, establishing ERP standard costs and training control owners; remediation was not complete as of the filing date.
- Potential liabilities remained from the former Brazilian subsidiary, including labor and civil claims. Management did not expect a material adverse outcome, but acknowledged uncertainty under Brazilian law.
Most important facts for investors to verify
- Whether COVID-19 demand translated into sustainable revenue and margin gains or primarily reflected temporary distributor and government stockpiling.
- The status and terms of the replacement revolving credit facility after the existing facility’s May 10, 2020 maturity date.
- Progress in remediating the inventory valuation material weakness and whether subsequent audits confirm effective controls.
- Inventory aging, valuation adjustments and potential excess inventory following the pandemic-driven production increase.
- The final outcome and remaining exposure from Brazilian labor and civil claims.
- The consistency of disclosed R&D guidance: approximately $0.7 million expected for FY2021 versus approximately $0.2 million reported in the FY2020 notes.
- The Company’s ability to maintain gross margins as trade policies, freight costs, raw-material prices and product mix change.